Bradley L. Campbell

Bradley Campbell has a diverse work experience spanning multiple industries. Bradley started their career as an Analyst at Marakon in 1997, where they worked until 1999. Bradley then joined Bristol-Myers Squibb in 1999 and served as an Associate Manager in Neuroscience, Infectious Diseases, and Dermatology, as well as a Manager of Strategy and Operations. In 2002, they moved to Genzyme and held positions as a Sr. Product Manager for Myozyme and a Business Director for Cardiovascular. Since 2006, Bradley has been with Amicus Therapeutics, initially as the President & Chief Operating Officer and later as the President and Chief Executive Officer.

Bradley Campbell completed their MBA in Business Administration from Harvard Business School from 2000 to 2002. Bradley also obtained a BA in Public Policy Studies from Duke University, where they studied from 1993 to 1997. Prior to their university education, Bradley attended Powers Catholic High School, but no specific degree or field of study is mentioned.